Current management options in metastatic renal cell cancer
Renal cancer accounts for 2.4% of all cancers. Localised disease accounts for the majority of renal cancers (70-75%), however 20-25% of these ultimately develop distant metastasis. The median overall survival of un treated metastatic disease is 5 months with 1-year survival of only 29%. The manageme...
Saved in:
Main Author: | Sittu Govindasamy Dinakaran Gangadaran (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck
by: Guenne C, et al.
Published: (2014) -
Up-and-Coming Experimental Drug Options for Metastatic Colorectal Cancer
by: Cimino SK, et al.
Published: (2020) -
Metastatic renal cell carcinoma in the nasopharynx
by: Yavuz Atar, et al.
Published: (2013) -
Targeting metastatic colorectal cancer – present and emerging treatment options
by: Ciombor KK, et al.
Published: (2014) -
Prostate cancer - current treatment options
by: Dawid Wardecki, et al.
Published: (2022)